Send to

Choose Destination
Biomed Khim. 2004 Jan-Feb;50(1):92-9.

[Plasma levels of mediator amino acids in patients with Parkinson disease].

[Article in Russian]

Author information

Institute of Neurology, Russian Academy of Medical Sciences, Volokolamskoe Shosse 80, 125367 Moscow, Russia.


Content of neurotransmitter amino acids before and after treatment with He-Ne-laser was measured in blood of two groups of the Parkinson's disease patients distinguished by low (first group) and high (second group) activity of monoamine oxidase B and Cu/Zn-superoxide dismutase. An increase in taurine level at the early stage of the disease (first group of patients) suggests that taurine may be a marker of compensatory abilities of the organism. The violation of the glutamate/taurine balance at the later stages of the disease and its normalization following the laserotherapy accompanied improvement of neurological symptoms.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center